Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00762528 · ClinicalTrials.gov registry record · Phase 4

Compare Anti-inflammatory Dentifrices

A Phase 4 study, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 4
Development phase
49
Enrollment target

NCT00762528: Completed Phase 4 study, sponsored by Colgate Palmolive.

NCT00762528 is a Phase 4 study that has completed, run by Colgate Palmolive. The registered enrollment target is 49 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00762528, a Phase 4 study, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 4
Development phase
49 participants
Enrollment target

Study Summary

Plaque induced gingivitis

Primary Outcome

Gingival Index(GI)recorded on scale of 0-3 detailed below: 0=normal gingiva, 1=Mild inflammation(slight change in color, slight edema)no bleeding on palpation,2=Moderate inflammation(redness,edema,glazing)bleeding upon probing, 3=Severe inflammation(marked redness,edema)ulceration \& tendency to spontaneously bleed

Interventions

  • DRUG Sodium monofluorophosphate toothpaste
  • DRUG Triclosan/Copolymer/fluoride toothpaste

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2009-02
Est. Completion 2010-02
Phase Phase 4
Colgate Palmolive

51 total trials

What the finished NCT00762528 record still lists

NCT00762528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Sodium monofluorophosphate toothpaste is the first listed.

NCT00762528 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00762528 about?

NCT00762528 is a clinical study titled "Compare Anti-inflammatory Dentifrices". Plaque induced gingivitis

What is the current status of trial NCT00762528?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2009-02. Estimated completion is 2010-02.

What interventions are being tested in trial NCT00762528?

The interventions under investigation include: Sodium monofluorophosphate toothpaste (DRUG), Triclosan/Copolymer/fluoride toothpaste (DRUG).

Who is sponsoring clinical trial NCT00762528?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00762528's enrollment target sits among peer trials

49 1323rd of 2000 higher than 670 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00762528, the US trial registry maintained by the National Library of Medicine. NCT00762528 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.